Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009) 2019-03-21 21:32
CStone received IND approval in China for HDAC6 inhibitor CS3003 2019-03-13 10:10
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
1 3 4 5 6 7